로딩 중…
지수 로딩 중…
Stoke Therapeutics, Inc.
STOK· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$31.00+2.45%
2026-06-18
Price Chart
Stoke Therapeutics, Inc.+167.93%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.93B |
| Revenue | $32M |
| Net Income | $-170M |
| Total Assets | $443M |
| Net Assets | $395M |
| Value | |
| P/B | 4.89x |
| P/S | 60.18x |
| FCF Yield | -7.65% |
| Profitability | |
| ROE | -42.99% |
| ROA | -38.30% |
| Op. Margin | -577.46% |
| Revenue Growth | -96.07% |
| Earnings Growth | -144.30% |
| Financial Health | |
| Debt Ratio | 12.26% |
| Total Debt | $3M |
| FCF | $-148M |
| Cash | $156M |
| Current Ratio | 8.99x |
| Performance | |
| 1Y Return | 167.93% |
| 1M Return | 3.47% |
| From 52W High | -22.92% |
| 1Y MDD | -37.16% |
| Trading | |
| Volume | 1,524,964 shares |
| Trading Value | $47M |
| Per Share | |
| EPS | $-0.12 |
| BPS | $6.04 |